Cypherpunk Technologies (CYPH) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Special Meeting of Stockholders scheduled for December 15, 2025, to be held virtually.
Stockholders of record as of October 24, 2025, are eligible to participate and vote.
Proxy materials, including the proxy statement and card, are available online for review.
Voting matters and shareholder proposals
Proposal to amend the Charter to increase authorized shares of common stock.
Proposal to amend the Charter to effect a reverse stock split.
Proposal to adopt the 2025 Equity Incentive Plan.
Proposal to approve issuance of more than 19.99% of common stock on warrant exercise, potentially triggering a Nasdaq "change of control."
Proposal to adjourn the meeting to solicit additional proxies if necessary.
Shareholder rights and capital structure
Board recommends voting in favor of all proposals, including changes to share authorization and potential equity issuance.
Voting can be conducted electronically during the meeting or in advance via internet or mobile device.
Latest events from Cypherpunk Technologies
- Returned to profitability in 2025 with strong ZEC gains, new capital, and clinical progress.CYPH
Q4 202516 Mar 2026 - Phase 2 trials for DKN-01 in gastric and colorectal cancer near key data readouts and expansion.CYPH
Piper Sandler 36th Annual Healthcare Conference11 Jan 2026 - Sirexatamab shows strong efficacy in GI cancer trials; FL-501 advances toward clinical studies.CYPH
43rd Annual J.P. Morgan Healthcare Conference 202510 Jan 2026 - Sirexatamab improved response rates in CRC, especially in DKK1-high and VEGF-naive patients.CYPH
Study Result9 Jan 2026 - Shareholders approved key proposals including share increase, reverse split, and new equity plan.CYPH
AGM 202515 Dec 2025 - Virtual meeting to elect directors, approve pay, and ratify auditor, with strong governance.CYPH
Proxy Filing2 Dec 2025 - Stockholders to vote on key capital, governance, and compensation proposals; Board urges approval.CYPH
Proxy Filing2 Dec 2025 - Virtual annual meeting on June 18, 2025, with key votes on directors, pay, and auditor.CYPH
Proxy Filing2 Dec 2025 - Sirexatamab delivers higher response rates and PFS in key colorectal cancer subgroups.CYPH
Status Update24 Nov 2025